Study reviews the impact of long COVID on individuals, health systems, and global economies, highlighting the need for a coordinated, patient-centered approach for future research and policy development.
When can observational studies support a drug’s effectiveness? FDA explains in new draft guidance
The FDA on Wednesday released highly-anticipated draft guidance on when drug sponsors can use observational studies to help demonstrate a drug’s effectiveness, for the first